These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 18855765)

  • 1. From the bakery to the brain business: developing inducible yeast models of human neurodegenerative disorders.
    Ocampo A; Barrientos A
    Biotechniques; 2008 Oct; 45(4):vii-xiv. PubMed ID: 18855765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beer and bread to brains and beyond: can yeast cells teach us about neurodegenerative disease?
    Gitler AD
    Neurosignals; 2008; 16(1):52-62. PubMed ID: 18097160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Harnessing the power of yeast to unravel the molecular basis of neurodegeneration.
    Tenreiro S; Munder MC; Alberti S; Outeiro TF
    J Neurochem; 2013 Nov; 127(4):438-52. PubMed ID: 23600759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Yeast as a platform to explore polyglutamine toxicity and aggregation.
    Duennwald ML
    Methods Mol Biol; 2013; 1017():153-61. PubMed ID: 23719914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monitoring polyglutamine toxicity in yeast.
    Duennwald ML
    Methods; 2011 Mar; 53(3):232-7. PubMed ID: 21144902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of polyglutamine-induced cytotoxicity in Saccharomyces cerevisiae by enhancement of mitochondrial biogenesis.
    Ocampo A; Zambrano A; Barrientos A
    FASEB J; 2010 May; 24(5):1431-41. PubMed ID: 20008543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Yeast models for amyloid disease.
    Panaretou B; Jones GW
    Essays Biochem; 2014; 56():85-97. PubMed ID: 25131588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Yeast as a drug discovery platform in Huntington's and Parkinson's diseases.
    Outeiro TF; Giorgini F
    Biotechnol J; 2006 Mar; 1(3):258-69. PubMed ID: 16897706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Yeast buddies helping to unravel the complexity of neurodegenerative disorders.
    Fruhmann G; Seynnaeve D; Zheng J; Ven K; Molenberghs S; Wilms T; Liu B; Winderickx J; Franssens V
    Mech Ageing Dev; 2017 Jan; 161(Pt B):288-305. PubMed ID: 27181083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simple is good: yeast models of neurodegeneration.
    Tenreiro S; Outeiro TF
    FEMS Yeast Res; 2010 Dec; 10(8):970-9. PubMed ID: 20579105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular genetics approaches in yeast to study amyloid diseases.
    Outeiro TF; Muchowski PJ
    J Mol Neurosci; 2004; 23(1-2):49-60. PubMed ID: 15126692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring the power of yeast to model aging and age-related neurodegenerative disorders.
    Oliveira AV; Vilaça R; Santos CN; Costa V; Menezes R
    Biogerontology; 2017 Feb; 18(1):3-34. PubMed ID: 27804052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Neurodegenerative amyloidoses: the yeast model].
    Vishnevskaia AB; Kushnirov VV; Ter-Avanesian MD
    Mol Biol (Mosk); 2007; 41(2):346-54. PubMed ID: 17514901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Developing yeast models of human neurodegenerative disorders.
    Ocampo A; Barrientos A
    Methods Mol Biol; 2011; 793():113-27. PubMed ID: 21913097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Yeast as a model for studying human neurodegenerative disorders.
    Miller-Fleming L; Giorgini F; Outeiro TF
    Biotechnol J; 2008 Mar; 3(3):325-38. PubMed ID: 18228539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein folding diseases and neurodegeneration: lessons learned from yeast.
    Winderickx J; Delay C; De Vos A; Klinger H; Pellens K; Vanhelmont T; Van Leuven F; Zabrocki P
    Biochim Biophys Acta; 2008 Jul; 1783(7):1381-95. PubMed ID: 18298958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.
    Calabrese V; Lodi R; Tonon C; D'Agata V; Sapienza M; Scapagnini G; Mangiameli A; Pennisi G; Stella AM; Butterfield DA
    J Neurol Sci; 2005 Jun; 233(1-2):145-62. PubMed ID: 15896810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Yeast as a model for studying neurodegeneration].
    Wawrzycka D
    Postepy Hig Med Dosw (Online); 2011 Jun; 65():328-37. PubMed ID: 21677357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sir2 is induced by oxidative stress in a yeast model of Huntington disease and its activation reduces protein aggregation.
    Sorolla MA; Nierga C; Rodríguez-Colman MJ; Reverter-Branchat G; Arenas A; Tamarit J; Ros J; Cabiscol E
    Arch Biochem Biophys; 2011 Jun; 510(1):27-34. PubMed ID: 21513696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic neurodegenerative diseases: the human illness and transgenic models.
    Price DL; Sisodia SS; Borchelt DR
    Science; 1998 Nov; 282(5391):1079-83. PubMed ID: 9804539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.